On November 3, medical technology firm Asker Healthcare Group announced that it acquired Swiss company Innomedicus.
Innomedicus is a niche distributor specializing in equipment and services for precision diagnostics and minimally invasive procedures in urology. The company is based in Switzerland and employs ten people. According to the original deal press release, Innomedicus reported revenues of approximately SEK 50 million (approximately $5.3 million USD) in 2024.
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients across Europe, providing medical products and solutions. The group focuses on improving patient outcomes, reducing the total cost of care and ensuring a fair and sustainable value chain. The group has more than 4,500 employees in 18 countries.
“[Innomedicus’] solid expertise and high-quality products and services have earned the trust of leading surgeons and urologists across Europe, said Johan Falk, CEO of Asker. “Together, we will be even better positioned to create value for healthcare providers and patients in Europe.”
The addition of Innomedicus is expected to have a positive impact on Asker’s EBITA margin. Financial details of the transaction remain confidential.
According to data captured in the LevinPro HC database, this transaction marks the 30th healthcare product distributor acquisition of the year. Asker is the most active buyer in the space with seven acquisitions in 2025, so far. There were 30 healthcare product distributor deals announced throughout all of 2024.
